John Prowle

Title: John Prowle: Innovator in Kidney Injury Prediction

Introduction

John Prowle is a notable inventor based in London, GB. He has made significant contributions to the field of medical science, particularly in the prediction of acute kidney injury. His innovative work has the potential to improve patient outcomes following critical surgical procedures.

Latest Patents

John Prowle holds a patent for "Markers for Acute Kidney Injury." This patent provides methods and compositions for predicting the development of kidney disease, including acute kidney injury. The methods are particularly useful for assessing kidney injury risk following events likely to cause kidney failure, such as cardiac surgeries involving cardiopulmonary bypass. The patent highlights the importance of urinary biomarkers, such as the hepcidin-to-creatinine ratio and the NGAL-to-creatinine ratio, in predicting the risk of acute kidney injury.

Career Highlights

Throughout his career, John Prowle has worked with various organizations, including Intrinsic Lifesciences LLC and Austin Health. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

John Prowle has collaborated with notable professionals, including Mark Westerman and Rinaldo Bellomo. These partnerships have enhanced his research and expanded the impact of his innovations in kidney injury prediction.

Conclusion

John Prowle's work in the field of acute kidney injury prediction exemplifies the importance of innovation in medical science. His contributions have the potential to significantly improve patient care and outcomes in critical situations.